Johnson & Johnson: Arthritis trials

The registry lists 100 Arthritis studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 37 have results posted.

Early Phase 1 1Phase 1 9Phase 2 16Phase 3 28Phase 4 21No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Anterior Advantage With KINCISETerminatedNCT04191733Not applicableResults posted
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT03733925Phase 4Results posted
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)CompletedNCT03162796Phase 3Results posted
• Usability of an AI for M923 in Subjects With Moderate to Severe RACompletedNCT02722044Phase 3Results posted
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)CompletedNCT02319759Phase 2Results posted
• A Study of Golimumab in Participants With Active Psoriatic ArthritisCompletedNCT02181673Phase 3Results posted
• A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid ArthritisCompletedNCT02019472Phase 3Results posted
• A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)TerminatedNCT01962974Phase 3Results posted
• Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003CompletedNCT01856309Phase 3Results posted
• A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or SulfasalazineCompletedNCT01689532Phase 3Results posted
• A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate TherapyCompletedNCT01645280Phase 2Results posted
• A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)CompletedNCT01606761Phase 3Results posted
• A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)CompletedNCT01604343Phase 3Results posted
• Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01248780Phase 3Results posted
• A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)TerminatedNCT01230827Phase 3Results posted
• Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)CompletedNCT01181050Phase 2Results posted
• A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF AgentsCompletedNCT01077362Phase 3Results posted
• A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisCompletedNCT01009086Phase 3Results posted
• Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)CompletedNCT01004432Phase 3Results posted
• An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyCompletedNCT00973479Phase 3Results posted
• First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid ArthritisCompletedNCT00927927Phase 1Results posted
• An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid ArthritisCompletedNCT00896168Phase 4Results posted
• A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint DiseaseCompletedNCT00784277Phase 3Results posted
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsCompletedNCT00760669Results posted
• A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00718718Phase 2Results posted
• RESTART C0168Z05 Rheumatoid Arthritis StudyCompletedNCT00714493Phase 4Results posted
• Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee SystemCompletedNCT00487565Not applicableResults posted
• A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00361335Phase 3Results posted
• Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip ReplacementTerminatedNCT00306917Not applicableResults posted
• A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)CompletedNCT00299546Phase 3Results posted
• Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKACompletedNCT00289107Not applicableResults posted
• Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKACompletedNCT00289094Not applicableResults posted
• An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic ArthritisCompletedNCT00267956Phase 2Results posted
• A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic ArthritisCompletedNCT00265096Phase 3Results posted
• An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00264550Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naiveCompletedNCT00264537Phase 3Results posted
• An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid ArthritisCompletedNCT00207714Phase 2Results posted
• A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or PsoriasisCompletedNCT05252533Phase 1
• A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic ArthritisTerminatedNCT05083078Phase 1
• A Study of JNJ-67484703 in Participants With Active Rheumatoid ArthritisCompletedNCT04985812Phase 1
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) TherapyCompletedNCT03796858Phase 3
• Golimumab for Adherence in Rheumatoid ArthritisCompletedNCT03729349
• A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting UstekinumabCompletedNCT03336281
• Cup Position in THA With Standard InstrumentsCompletedNCT03189303
• Tracking Biologics Along the Silk RoadCompletedNCT03006198
• Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid ArthritisCompletedNCT02728934
• A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic ArthritisCompletedNCT02627768
• A Study in Participants With Psoriatic Arthritis Attending Dermatology ClinicsCompletedNCT02470481
• Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to GolimumabTerminatedNCT02414984
• Observational Study of Golimumab Intravenous InfusionTerminatedNCT02390700
• An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01909427Phase 2
• A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyTerminatedNCT01862224Phase 2
• A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisWithdrawnNCT01692457
• A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With MethotrexateTerminatedNCT01679951Phase 2
• A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid ArthritisCompletedNCT01636557Phase 1
• Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement SurgeryTerminatedNCT01635166Phase 4
• A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug TherapyCompletedNCT01597739Phase 2
• Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEMCompletedNCT01529099Phase 4
• A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With MethotrexateWithdrawnNCT01480388Phase 2
• A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsCompletedNCT01450982Phase 1
• A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsCompletedNCT01442545Phase 1
• A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement SurgeryTerminatedNCT01383824Not applicable
• A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)CompletedNCT01362153Phase 1
• A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in KoreaCompletedNCT01294722
• An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip ReplacementTerminatedNCT01134445Phase 4
• An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid ArthritisTerminatedNCT00941707Phase 2
• A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing SurgeryTerminatedNCT00872794Phase 4
• A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip ReplacementTerminatedNCT00872573Phase 4
• Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip ReplacementTerminatedNCT00872547Phase 4
• A Single Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-ceramic Bearing in Primary Total Hip ReplacementTerminatedNCT00872222Phase 4
• A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip ReplacementCompletedNCT00872066Phase 4
• Biologic Treatment Registry Across CanadaCompletedNCT00741793
• A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00727987Phase 3
• Remicade Infusion Management ProgramCompletedNCT00723905
• Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisCompletedNCT00658827
• A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorCompletedNCT00643526Early Phase 1
• A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or OsteoarthritisCompletedNCT00524160Phase 4
• A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid ArthritisCompletedNCT00508768Phase 1
• An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.CompletedNCT00440817
• Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00425321Phase 2
• APART Advanced Profiling of Anti-Rheumatic TherapiesCompletedNCT00378261Phase 4
• Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
• Clinical Study Evaluating an Acetabular Cup System After Total Hip ReplacementCompletedNCT00306930Not applicable
• Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee ProsthesesTerminatedNCT00289081Not applicable
• Infliximab Plus Methotrexate for the Treatment of Rheumatoid ArthritisCompletedNCT00269867Phase 3
• A Long-term Safety Study of Infliximab (Remicade)CompletedNCT00261976
• ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.CompletedNCT00246168Phase 4
• The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) ProtocolCompletedNCT00246064Phase 4
• Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRITTerminatedNCT00236678Phase 2
• A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With OsteoarthritisCompletedNCT00236366Phase 4
• A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid ArthritisCompletedNCT00236028Phase 3
• A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip ReplacementTerminatedNCT00208455Phase 4
• A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip ReplacementWithdrawnNCT00208429Phase 4
• A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip ReplacementTerminatedNCT00208390Phase 4
• A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing SurgeryTerminatedNCT00208377Phase 4
• A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip ReplacementTerminatedNCT00208364Phase 4
• SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving MethotrexateCompletedNCT00089921Phase 2
• A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic ArthritisCompletedNCT00051623Phase 3
• Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving MethotrexateCompletedNCT00043732Phase 2
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid ArthritisCompletedNCT00036374Phase 3